Stay updated on CV301-Nivolumab Combo in Metastatic CRC Clinical Trial
Sign up to get notified when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.

Latest updates to the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded site revision v3.4.2 and removed the earlier v3.4.1 funding/operations notice; changes are limited to system messages and do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange Detected- Added a site-wide notice regarding government funding lapse and NIH CC operating status. - Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a Show glossary option and updated metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data) with a new revision tag (v3.4.0), while older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4) were removed. These changes pertain to UI and documentation details rather than core study content or functionality.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision history shows addition of Revision: v3.3.4 and deletion of Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section reorganized into a consolidated Locations section, removing the prior per-state headings (California, Florida, Kansas, New Jersey, Ohio, Oregon) and updating the revision to v3.3.3.SummaryDifference0.7%

- Check92 days agoChange DetectedPage revision tag updated from v3.2.0 to v3.3.2; no user-facing content or study details were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to CV301-Nivolumab Combo in Metastatic CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.